Hypointense hepatic lesions depicted on gadobenate dimeglumine-enhanced three-hour delayed hepatobiliary-phase MR imaging: Differentiation between benignancy and malignancy

Korean Journal of Radiology

Volumn 10, Issue 3, 2009, Pages 294-302

  Hye, Sun Hwang ^a   Seong, Hyun Kim ^a   Tae, Yeon Jeon ^a   Choi, Dongil ^a   Won, Jae Lee ^a   Lim, Hyo K ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Diagnosis; Gadobenate dimeglumine; Liver neoplasm; Magnetic resonance (MR)

Indexed keywords

GADOBENATE DIMEGLUMINE;

ADVANCED CANCER; ANGIOMYOLIPOMA; ARTICLE; BENIGN TUMOR; BILE DUCT CARCINOMA; BILIARY EXCRETION; BILIARY TRACT DISEASE; CANCER DIAGNOSIS; CELL FUNCTION; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; EOSINOPHILIC GRANULOMA; FOCAL EOSINOPHILIC LIVER DISEASE; FUZZY SYSTEM; HEPATITIS; HEPATOBILIARY RADIOGRAPHY; HUMAN; LIVER ADENOMA; LIVER CANCER; LIVER CELL; LIVER CELL CARCINOMA; LIVER CELL DAMAGE; LIVER CYST; LIVER DISEASE; LIVER FIBROSIS; LIVER GRANULOMA; LIVER HEMANGIOMA; LIVER NODULE; LIVER PARENCHYMA; LIVER TUMOR; LYMPHOID HYPERPLASIA; MESENCHYMOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; SOLITARY FIBROUS TUMOR; TUMOR BIOPSY; TUMOR DIAGNOSIS;

ADULT; AGED; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE ENHANCEMENT; LIVER; LIVER DISEASES; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MEGLUMINE; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; TIME;

EID: 66849124578     PISSN: 12296929     EISSN: None     Source Type: Journal    
DOI: 10.3348/kjr.2009.10.3.294     Document Type: Article

References (30)

1. Cavagna FM, Maggioni F, Castelli PM, Daprà M, Imperatori LG, Lorusso V, et al. Gadolinium chelates with weak binding to serum proteins. A new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 1997;32:780-796 (Pubitemid 28053510)
2. Kirchin MA, Pirovano GP, Spinazzi A. Gadobenate dimeglumine (Gd-BOPTA). An overview. Invest Radiol 1998;33:798-809 (Pubitemid 30247065)
3. Spinazzi A, Lorusso V, Pirovano G, Kirchin M. Safety, tolerance, biodistribution and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers. Acad Radiol 1999;6:282-291 (Pubitemid 32673373)
4. Bartolozzi C, Crocetti L, Lencioni R, Cioni D, Della Pina C, Campani D. Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media. Eur Radiol 2007;17:2519-2530
5. Petersein J, Spinazzi A, Giovagnoni A, Soyer P, Terrier F, Lencioni R, et al. Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging-a multicenter phase III clinical study. Radiology 2000;215:727-736 (Pubitemid 30346007)
6. Kim YK, Lee JM, Kim CS. Gadobenate dimeglumine-enhanced liver MR imaging: value of dynamic and delayed imaging for the characterization and detection of focal liver lesions. Eur Radiol 2004;14:5-13 (Pubitemid 38181049)
7. Grazioli L, Morana G, Federle MP, Brancatelli G, Testoni M, Kirchin MA, et al. Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine. Radiology 2001;221:731-739 (Pubitemid 33101765)
8. Grazioli L, Morana G, Kirchin MA, Schneider G. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR imaging: prospective study. Radiology 2005;236:166-177 (Pubitemid 40853309)
9. Leen E. MultiHance-enhanced MRI in the characterisation of focal liver lesions. Eur Radiol 2004;14:O31-O35 (Pubitemid 39214069)
10. Kim JI, Lee JM, Choi JY, Kim YK, Kim SH, Lee JY, et al. The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver. Invest Radiol 2008;43:202-210
11. Runge VM, Wells JW, Williams NM. Hepatic abscess. Magnetic resonance imaging findings using gadolinium-BOPTA. Invest Radiol 1996;31:781-788 (Pubitemid 26425423)
12. Marin D, Iannaccone R, Catalano C, Passariello R. Multinodular focal fatty infiltration of the liver: atypical imaging findings on delayed T1-weighted Gd-BOPTA-enhanced liver-specific MR images. J Magn Reson Imaging 2006;24:690-694 (Pubitemid 44320574)
13. Schneider G, Fries P, Samaras P, Remberger K, Uder M, Kramann B. Inflammatory pseudotumor of the liver in a patient with congenital granulocytopenia and HCV infection. Eur J Radiol 2003;48:293-298 (Pubitemid 37491069)
14. Pascolo L, Petrovic S, Cupelli F, Bruschi CV, Anelli PL, Lorusso V, et al. Abc protein transport of MRI contrast agents in canalicular rat liver plasma vesicles and yeast vacuoles. Biochem Biophys Res Commun 2001;282:60-66 (Pubitemid 32924345)
15. Pastor CM, Planchamp C, Pochon S, Lorusso V, Montet X, Mayer J, et al. Kinetics of gadobenate dimeglumine in isolated perfused rat liver: MR imaging evaluation. Radiology 2003;229:119-125 (Pubitemid 37152113)
16. Meier PJ, Eckhardt U, Schroeder A, Hagenbuch B, Stieger B. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. Hepatology 1997;26:1667-1677 (Pubitemid 27520039)
17. Stanca C, Jung D, Meier PJ, Kullak-Ublick GA. Hepatocellular transport proteins and their role in liver disease. World J Gastroenterol 2001;7:157-169 (Pubitemid 32377465)
18. Spinazzi A, Lorusso V, Pirovano G, Taroni P, Kirchin MA, Davies A. Multihance clinical pharmacology: biodistribution and MR enhancement of the liver. Acad Radiol 1998;5:S86-S89
19. Gabata T, Matsui O, Kadoya M, Yoshikawa J, Ueda K, Kawamori Y, et al. Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance. Abdom Imaging 1998;23:309-313 (Pubitemid 28213309)
20. Mahfouz AE, Hamm B, Wolf KJ. Peripheral washout: a sign of malignancy on dynamic gadolinium-enhanced MR images of focal liver lesions. Radiology 1994:190:49-52 (Pubitemid 24017000)
21. Nath DS, Rutzick AD, Sielaff TD. Solitary fibrous tumor of the liver. AJR Am J Roentgenol 2006;187:W187-W190
22. Fuksbrumer MS, Klimstra D, Panicek DM. Solitary fibrous tumor of the liver: imaging findings. AJR Am J Roentgenol 2000;175:1683-1687
23. Machida T, Takahashi T, Itoh T, Hirayama M, Morita T, Horita S. Reactive lymphoid hyperplasia of the liver: a case report and review of literature. World J Gastroenterol 2007;13:5403-5407 (Pubitemid 47559478)
24. Takahashi H, Sawai H, Matsuo Y, Funahashi H, Satoh M, Okada Y, et al. Reactive lymphoid hyperplasia of the liver in a patient with colon cancer: report of two cases. BMC Gastroenterol 2006;6:25 (Pubitemid 44489788)
25. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH. NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 1982;97:78-92 (Pubitemid 12091287)
26. Lee WJ, Lim HK, Lim JH, Kim SH, Choi SH, Lee SJ. Foci of eosinophil-related necrosis in the liver: imaging findings and correlation with eosinophilia. AJR Am J Roentgenol 1999;172:1255-1261 (Pubitemid 29507616)
27. Lim JH, Lee KS. Eosinophilic infiltration in Korea: idiopathic? Korean J Radiol 2006;7:4-6
28. Leese T, Farges O, Bismuth H. Liver cell adenomas. A 12-year surgical experience from a specialist hepato-biliary unit. Ann Surg 1988;208:558-564 (Pubitemid 18267695)
29. Caudana R, Morana G, Pirovano GP, Nicoli N, Portuese A, Spinazzi A, et al. Focal malignant hepatic lesions: MR imaging enhanced with gadolinium benzyloxypropionictetra-acetate (BOPTA)-preliminary results of phase II clinical application. Radiology 1996;199:513-520 (Pubitemid 26124278)
30. Muramatsu Y, Takayasu K, Moriyama N, Shima Y, Goto H, Ushio K, et al. Peripheral low-density area of hepatic tumors: CT-pathologic correlation. Radiology 1986;160:49-52 (Pubitemid 16090072)